Stephen A. Smith Apologizes for Mocking Lane Johnson's Mental Health Retirement
ESPN host Stephen A. Smith apologized on "First Take" on Thursday for making light of Eagles lineman Lane Johnson's decision to retire from football to address his mental health and be with his family. Smith said his biggest regret was that mocking mental health struggles could discourage people from seeking help, and praised Johnson's openness as courageous.
Source: USA Today FDA Cites 4 Deaths in Clinical Hold on Newron's Schizophrenia Drug Trial
Newron Pharmaceuticals said the FDA outlined safety concerns behind its clinical hold on U.S. enrollment in a late-stage trial of evenamide, an experimental drug for treatment-resistant schizophrenia, citing four deaths and irregular heart rhythms among patients. Investigators considered three of the four deaths unrelated to the drug, and the company said it is reviewing additional heart screening and monitoring measures.
Source: Reuters NHS Launches "World's Largest" Mental Health Study, Recruiting 49,000 Volunteers
The GlobalMinds study is inviting nearly 50,000 adults in England and Wales diagnosed with bipolar disorder, schizophrenia, psychosis, or major depression to take part in a three-year project combining DNA samples, questionnaires, and medical records. Led by Cardiff University and Akrivia Health, researchers aim to build the most detailed dataset ever assembled for serious mental health conditions and pave the way for personalized treatments.
Source: UKAuthority
ESPN host Stephen A. Smith apologized on "First Take" on Thursday for making light of Eagles lineman Lane Johnson's decision to retire from football to address his mental health and be with his family. Smith said his biggest regret was that mocking mental health struggles could discourage people from seeking help, and praised Johnson's openness as courageous.
Source: USA Today FDA Cites 4 Deaths in Clinical Hold on Newron's Schizophrenia Drug Trial
Newron Pharmaceuticals said the FDA outlined safety concerns behind its clinical hold on U.S. enrollment in a late-stage trial of evenamide, an experimental drug for treatment-resistant schizophrenia, citing four deaths and irregular heart rhythms among patients. Investigators considered three of the four deaths unrelated to the drug, and the company said it is reviewing additional heart screening and monitoring measures.
Source: Reuters NHS Launches "World's Largest" Mental Health Study, Recruiting 49,000 Volunteers
The GlobalMinds study is inviting nearly 50,000 adults in England and Wales diagnosed with bipolar disorder, schizophrenia, psychosis, or major depression to take part in a three-year project combining DNA samples, questionnaires, and medical records. Led by Cardiff University and Akrivia Health, researchers aim to build the most detailed dataset ever assembled for serious mental health conditions and pave the way for personalized treatments.
Source: UKAuthority